» Articles » PMID: 1473549

Interferon Alpha-2a Therapy of Consumptive Coagulopathy in Kasabach-Merritt Syndrome

Overview
Journal Eur J Pediatr
Specialty Pediatrics
Date 1992 Dec 1
PMID 1473549
Authors
Affiliations
Soon will be listed here.
References
1.
Ezekowitz R, Mulliken J, Folkman J . Interferon alfa-2a therapy for life-threatening hemangiomas of infancy. N Engl J Med. 1992; 326(22):1456-63. DOI: 10.1056/NEJM199205283262203. View

2.
Warrell Jr R, Kempin S . Treatment of severe coagulopathy in the Kasabach-Merritt syndrome with aminocaproic acid and cryoprecipitate. N Engl J Med. 1985; 313(5):309-12. DOI: 10.1056/NEJM198508013130507. View

3.
Eldor A, Fridman R, Vlodavsky I, Fuks Z, Panet A . Interferon enhances prostacyclin production by cultured vascular endothelial cells. J Clin Invest. 1984; 73(1):251-7. PMC: 425007. DOI: 10.1172/JCI111198. View

4.
Folkman J . Successful treatment of an angiogenic disease. N Engl J Med. 1989; 320(18):1211-2. DOI: 10.1056/NEJM198905043201811. View

5.
Ozsoylu S, Irken G, Gurgey A . High dose intravenous methylprednisolone for Kassabach-Merritt syndrome. Eur J Pediatr. 1989; 148(5):403-5. DOI: 10.1007/BF00595897. View